Seres Therapeutics, Inc. (MCRB) Free Cash Flow by Year
Seres Therapeutics, Inc. generated $865K in free cash flow in fiscal year 2025. This represents an increase of 100.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $51.3M in free cash flow. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Seres Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MCRB Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -$51.3M | $865K+100.6% | -$149.0M-18.9% | -$125.3M+47.5% | -$238.6M-8191.8% | -$2.9M+96.9% | -$94.2M-21.5% | -$77.5M-19.6% | -$64.8M+19.2% | -$80.2M-457.6% | $22.4M+149.6% | -$45.2M-298.0% | -$11.4M-106.7% | -$5.5M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
MCRB Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Seres Therapeutics, Inc. financials
Frequently Asked Questions
What was Seres Therapeutics, Inc.'s free cash flow in fiscal year 2025?
Seres Therapeutics, Inc. generated $865K in free cash flow in fiscal year 2025.
How fast is Seres Therapeutics, Inc.'s free cash flow growing?
Seres Therapeutics, Inc. (MCRB) free cash flow rose by 100.6% year over year, from -$149.0M to $865K in fiscal year 2025.
What is Seres Therapeutics, Inc.'s free cash flow over the last twelve months?
Seres Therapeutics, Inc. (MCRB) reported an outflow of $51.3M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Seres Therapeutics, Inc.'s free cash flow changed over the years?
Across the 13 fiscal years this page covers, Seres Therapeutics, Inc. (MCRB) free cash flow went from -$5.5M in fiscal year 2013 to $865K in fiscal year 2025.
What was Seres Therapeutics, Inc.'s free cash flow in the most recent quarter?
Seres Therapeutics, Inc. (MCRB) reported -$22.4M in free cash flow in Q2 2026. This represents a decrease of 66.3% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Seres Therapeutics, Inc. (MCRB) reported on that line in every period on record.